We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
CIP LATANOPROST, LATANOPROST CIP, LATANOPROST CA (Cipla Australia Pty Ltd)
Product name
CIP LATANOPROST, LATANOPROST CIP, LATANOPROST CA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
115 working days (255)
Active ingredients
latanoprost
Registration type
New generic medicine
Indication
CIP LATANOPROST/LATANOPROST CIP/LATANOPROST CA (eye drops) is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.